J&J MedTech MONARCH QUEST for Enhanced Robotic-Assisted Bronchoscopy OKd

 

Next-generation NVIDIA-powered AI navigation software elevates MONARCH^TM Platform for Robotically Assisted Bronchoscopy

Johnson & Johnson MedTech, a global leader in surgical technologies and solutions, today announced U.S. 510(k) regulatory clearance for MONARCH QUEST, the latest advancement in MONARCH navigation technology, featuring AI-powered algorithms and a verified OEC Open interface with the GE HealthCare OEC 3D mobile CBCT Imaging System.

Robotically assisted bronchoscopy represents a small but fast-growing segment of lung biopsy procedures in the U.S. The MONARCH Platform, the first robotically assisted bronchoscopy system to market, provides minimally invasive access to and visualization of airways to help clinicians biopsy suspicious lung nodules.

Nearly half of early-stage lesions are located in the periphery of the lung, which is difficult to reach with traditional bronchoscopy[1]. The MONARCH Platform can aid clinicians in getting to an early, definitive diagnosis in lung cancer cases, which can help care teams get patients into the treatment pathway an average of three weeks faster

https://www.jnj.com/media-center/press-releases/johnson-johnson-medtech-announces-clearance-of-monarchtm-quest-for-enhanced-robotic-assisted-bronchoscopy